Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model - Details

author：

Indexed by：

Scopus

Abstract：

Background:　Although　it　has　been　preclinically　suggested　that　adipose　tissue-derived　mesenchymal　stem　cell　(ADSC)-based　therapy　could　effectively　treat　chronic　liver　diseases,　the　hepatic　engraftment　of　ADSCs　is　still　extremely　low,　which　severely　limits　their　long-term　efficacy　for　chronic　liver　diseases.　This　study　was　designed　to　investigate　the　impact　of　antioxidant　preconditioning　on　hepatic　engraftment　efficiency　and　therapeutic　outcomes　of　ADSC　transplantation　in　liver　fibrotic　mice.　Methods:　Liver　fibrosis　model　was　established　by　using　intraperitoneal　injection　of　carbon　tetrachloride　(CCl4)　in　the　male　C57BL/6　mice.　Subsequently,　the　ADSCs　with　or　without　antioxidant　pretreatment　(including　melatonin　and　reduced　glutathione　(GSH))　were　administrated　into　fibrotic　mice　via　tail　vein　injection.　Afterwards,　the　ADSC　transplantation　efficiency　was　analyzed　by　ex　vivo　imaging,　and　the　liver　functions　were　assessed　by　biochemical　analysis　and　histopathological　examination,　respectively.　Additionally,　a　typical　hydrogen　peroxide　(H2O2)-induced　cell　injury　model　was　applied　to　mimic　the　cell　oxidative　injury　to　further　investigate　the　protective　effects　of　antioxidant　preconditioning　on　cell　migration,　proliferation,　and　apoptosis　of　ADSCs.　Results:　Our　data　showed　that　antioxidant　preconditioning　could　enhance　the　therapeutic　effects　of　ADSCs　on　liver　function　recovery　by　reducing　the　level　of　AST,　ALT,　and　TBIL,　as　well　as　the　content　of　hepatic　hydroxyproline　and　fibrotic　area　in　liver　tissues.　Particularly,　we　also　found　that　antioxidant　preconditioning　could　enhance　hepatic　engraftment　efficiency　of　ADSCs　in　liver　fibrosis　model　through　inhibiting　oxidative　injury.　Conclusions:　Antioxidant　preconditioning　could　effectively　improve　therapeutic　effects　of　ADSC　transplantation　for　liver　fibrosis　through　enhancing　intrahepatic　engraftment　efficiency　by　reducing　oxidative　injuries.　These　findings　might　provide　a　practical　strategy　for　enhancing　ADSC　transplantation　and　therapeutic　efficiency.　©　2020　The　Author(s).

Keyword：

Adipose tissue-derived mesenchymal stem cells; Cell engraftment efficiency; Liver fibrosis; Reactive oxygen species; Stem cell therapy

Community：

[ 1 ] [Liao, N.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 2 ] [Liao, N.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 3 ] [Liao, N.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 4 ] [Liao, N.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 5 ] [Liao, N.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 6 ] [Liao, N.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 7 ] [Liao, N.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 8 ] [Liao, N.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 9 ] [Liao, N.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 10 ] [Shi, Y.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 11 ] [Shi, Y.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 12 ] [Shi, Y.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 13 ] [Wang, Y.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 14 ] [Wang, Y.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 15 ] [Wang, Y.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 16 ] [Liao, F.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 17 ] [Liao, F.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 18 ] [Liao, F.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 19 ] [Zhao, B.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 20 ] [Zhao, B.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 21 ] [Zhao, B.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 22 ] [Zheng, Y.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 23 ] [Zheng, Y.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 24 ] [Zheng, Y.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 25 ] [Zeng, Y.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 26 ] [Zeng, Y.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 27 ] [Zeng, Y.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 28 ] [Zeng, Y.]Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China
[ 29 ] [Liu, X.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 30 ] [Liu, X.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 31 ] [Liu, X.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 32 ] [Liu, J.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 33 ] [Liu, J.]Liver Disease Center, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 34 ] [Liu, J.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 35 ] [Liu, J.]Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China

Reprint 's Address：

[Liu, X.]United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical UniversityChina

Email：

xiaoloong.liu@gmail.com

Show more details

Related Keywords：

Source ：

Stem Cell Research and Therapy

ISSN： 1757-6512

Year： 2020

Issue： 1

Volume： 11

4 . 6 2 7

JCR@2018

CAS Journal Grade：2

Cited Count：

WoS CC Cited Count：

SCOPUS Cited Count： 37

ESI Highly Cited Papers on the List： 0 Unfold All

WanFang Cited Count：

Chinese Cited Count：

30 Days PV： 0

Affiliated Colleges：

Get Fulltext

DOI Library Discovery Baidu Scholar Search SCOPUS

Type
Departments

All Years Choose Year From to